DE69701662D1 - N-substituierte zyklische Amine, ihre Herstellungsverfahren und sie enthaltende pharmazeutische Zusammensetzungen - Google Patents

N-substituierte zyklische Amine, ihre Herstellungsverfahren und sie enthaltende pharmazeutische Zusammensetzungen

Info

Publication number
DE69701662D1
DE69701662D1 DE69701662T DE69701662T DE69701662D1 DE 69701662 D1 DE69701662 D1 DE 69701662D1 DE 69701662 T DE69701662 T DE 69701662T DE 69701662 T DE69701662 T DE 69701662T DE 69701662 D1 DE69701662 D1 DE 69701662D1
Authority
DE
Germany
Prior art keywords
halo
saturated
optionally substituted
unsaturated
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69701662T
Other languages
English (en)
Other versions
DE69701662T2 (de
Inventor
Alain Dhainaut
Andre Tizot
Emmanuel Canet
Michel Lonchampt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of DE69701662D1 publication Critical patent/DE69701662D1/de
Publication of DE69701662T2 publication Critical patent/DE69701662T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
DE69701662T 1996-09-20 1997-09-19 N-substituierte zyklische Amine, ihre Herstellungsverfahren und sie enthaltende pharmazeutische Zusammensetzungen Expired - Fee Related DE69701662T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9611501A FR2753706B1 (fr) 1996-09-20 1996-09-20 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
DE69701662D1 true DE69701662D1 (de) 2000-05-18
DE69701662T2 DE69701662T2 (de) 2000-11-23

Family

ID=9495928

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69701662T Expired - Fee Related DE69701662T2 (de) 1996-09-20 1997-09-19 N-substituierte zyklische Amine, ihre Herstellungsverfahren und sie enthaltende pharmazeutische Zusammensetzungen

Country Status (18)

Country Link
US (1) US5919801A (de)
EP (1) EP0831090B1 (de)
JP (1) JPH10101645A (de)
AT (1) ATE191717T1 (de)
AU (1) AU718489B2 (de)
BR (1) BR9704757A (de)
CA (1) CA2216664C (de)
DE (1) DE69701662T2 (de)
DK (1) DK0831090T3 (de)
ES (1) ES2147427T3 (de)
FR (1) FR2753706B1 (de)
GR (1) GR3033509T3 (de)
HU (1) HU221811B1 (de)
NO (1) NO313997B1 (de)
NZ (1) NZ328789A (de)
PL (1) PL322192A1 (de)
PT (1) PT831090E (de)
ZA (1) ZA978462B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL346345A1 (en) * 1998-05-22 2002-02-11 Scios Inc Heterocyclic compounds and methods to treat cardiac failure and other disorders
US6340685B1 (en) 1998-05-22 2002-01-22 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6867209B1 (en) 1998-05-22 2005-03-15 Scios, Inc. Indole-type derivatives as inhibitors of p38 kinase
US6448257B1 (en) 1998-05-22 2002-09-10 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6589954B1 (en) 1998-05-22 2003-07-08 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6130235A (en) * 1998-05-22 2000-10-10 Scios Inc. Compounds and methods to treat cardiac failure and other disorders
DZ2876A1 (fr) * 1998-08-26 2003-12-15 Smithkline Beecham Corp Composition comprenant un inhibiteur de pde4 et unbroncho-dilatateur beta-andrenergique, et procédé pour leur préparation.
IL146309A (en) 1999-05-21 2008-03-20 Scios Inc Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38
KR100515905B1 (ko) * 2000-01-31 2005-09-21 주식회사 엘지생명과학 피롤아미드의 새로운 제조방법
PL356447A1 (en) * 2000-02-08 2004-06-28 Smithkline Beecham Corporation Method and compositions for treating an inflammatory disease
US20030207845A1 (en) * 2001-02-08 2003-11-06 Keating Elizabeth T. Method and compositions for treating an inflammatory disease
DE10035927A1 (de) 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10035928A1 (de) 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
PL205307B1 (pl) * 2000-08-11 2010-04-30 Ono Pharmaceutical Co Pochodna piperydyny oraz środek do zapobiegania chorobom i/lub ich leczenia zawierający jako substancję czynną tę pochodną
US20040219552A1 (en) * 2001-08-14 2004-11-04 Ali Ait Ikhlef Novel molecular target for neurotoxicity
FR2856595B1 (fr) * 2003-06-27 2008-05-30 Exonhit Therapeutics Sa Methodes et compositions pour le traitement de deficits cognitifs.
CA2722611A1 (en) 2007-11-21 2009-05-28 Decode Genetics Ehf Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6850M (de) * 1967-12-05 1969-04-08
US5459151A (en) * 1993-04-30 1995-10-17 American Home Products Corporation N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
US5530012A (en) * 1994-12-22 1996-06-25 Bristol-Myers Squibb Co. 3-alkoxybenzylpiperidine derivatives as melatonergic agents
US5703239A (en) * 1995-06-02 1997-12-30 Bristol-Myers Squibb Company Indanylpiperidines as melatonergic agents

Also Published As

Publication number Publication date
ES2147427T3 (es) 2000-09-01
FR2753706B1 (fr) 1998-10-30
HU9701561D0 (en) 1997-11-28
DE69701662T2 (de) 2000-11-23
ZA978462B (en) 1998-03-24
NZ328789A (en) 1998-02-26
EP0831090A1 (de) 1998-03-25
DK0831090T3 (da) 2000-09-11
GR3033509T3 (en) 2000-09-29
HUP9701561A2 (hu) 1998-05-28
PL322192A1 (en) 1998-03-30
PT831090E (pt) 2000-07-31
FR2753706A1 (fr) 1998-03-27
CA2216664A1 (fr) 1998-03-20
US5919801A (en) 1999-07-06
HU221811B1 (hu) 2003-01-28
CA2216664C (fr) 2002-05-21
ATE191717T1 (de) 2000-04-15
BR9704757A (pt) 1998-09-01
AU3836297A (en) 1998-03-26
HUP9701561A3 (en) 1998-07-28
JPH10101645A (ja) 1998-04-21
NO974253D0 (no) 1997-09-15
AU718489B2 (en) 2000-04-13
EP0831090B1 (de) 2000-04-12
NO974253L (no) 1998-03-23
NO313997B1 (no) 2003-01-13

Similar Documents

Publication Publication Date Title
DE69701662D1 (de) N-substituierte zyklische Amine, ihre Herstellungsverfahren und sie enthaltende pharmazeutische Zusammensetzungen
AR065937A2 (es) Compuesto derivado indazol, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para modular la actividad de proteina quinasa
AR030189A1 (es) Compuesto de benzotiazol, uso del mismo para preparar una composicion farmaceutica y dicha composicion farmaceutica
ATE110075T1 (de) 1,2-benzisoxazolderivate, verfahren zu deren herstellung, und sie enthaltende pharmazeutische zusammensetzungen.
AR032130A1 (es) Un compuesto inhibidor de quinasas proteicas, una composicion farmaceutica que lo incluye, y un metodo para tratar afecciones con dicho compuesto
ITMI921203A1 (it) Derivati di s-triazina come agenti fotostabilizzanti
MX9102582A (es) Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
AR005357A1 (es) Derivados de 14-o-carbamoil mutilina y sus sales utiles en el tratamiento de infecciones bacterianas, procedimiento para prepararlas, composicionesfarmaceuticas formuladas con dichos derivados y uso de los mismos para preparar dichas composiciones
ES2115058T3 (es) Derivados basicos de acido glutamico y acido aspartico como antagonistas de la gastrina o colecistoquinina.
NO20004295D0 (no) Nye pyridinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
CO4970807A1 (es) Compuestos de indol 2,3 sustituidos como agentes anti-infla matorios y analgesicos
AR008296A1 (es) Compuestos derivados de tetrahidroquinolina, proceso para su preparacion, composiciones que los contienen y su uso en la preparacion de una composicion
ES2078267T3 (es) H-heteroaril-purin-6-aminas, un procedimiento para su preparacion y su uso como medicamentos.
YU49346B (sh) TRICIKLICNI 5,6-DIHIDRO-9H-PIRAZOLO [3,4-c] -1,2,4-TRIAZOLO [4,3-α] PIRIDINI
ES2133544T3 (es) Derivados de indazol.
ES2063117T3 (es) Derivados del tieno(2,3-d)acepina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
ES2095848T3 (es) Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos.
EA200101204A1 (ru) Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции
AR037140A1 (es) Un compuesto de aminopirrol, su utilizacion, un procedimiento para producirlo y una composicion que lo comprende
ES2063157T3 (es) Nuevos derivados del indol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
FR2632522B1 (fr) Nouveaux derives de la phenothiazine, leur preparation et les compositions qui les contiennent
ES2136667T3 (es) Compuestos de etinil-alanina-amino-diol que tienen un grupo terminado en piperazinilo o un grupo terminado en piperazinil-alquilamino para el tratamiento de la hipertension.
DK0850939T3 (da) Ellipticin-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende derivaterne
AR010853A1 (es) Derivados de benzopirano, (co)polimero y/o reticulado, compuesto fotocromatico, composicion fotocromatica, matriz (co)polimerica, articulooftalmico o solar y cristal o dispositivo optico que comprenden dichos derivados

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR

8339 Ceased/non-payment of the annual fee